Cancer induced bone pain: current management and future perspectives

Area of Science:

• Oncology
• Pain Medicine
• Cancer Metastasis

Background:

• Improved cancer therapeutics have increased patient survival, resulting in a higher incidence of bone metastasis.
• Bone metastasis frequently leads to cancer-induced bone pain (CIBP), a debilitating condition significantly impacting quality of life (QoL).
• CIBP arises from complex interactions between tumor cells, bone cells, the inflammatory microenvironment, and neural tissue.

Purpose of the Study:

• To review the pathogenesis and pathophysiology of bone metastasis and CIBP.
• To discuss currently approved therapies for CIBP management.
• To explore future perspectives in CIBP treatment.

Main Methods:

• Literature review of pathogenesis, pathophysiology, and therapeutic strategies for CIBP.
• Analysis of current approved medical, surgical, radiation, and behavioral interventions.
• Synthesis of information on future research directions and potential treatments.

Main Results:

• CIBP is a multifactorial condition requiring a comprehensive management strategy.
• Current management focuses on mitigating pain to achieve an acceptable QoL.
• Multimodality treatment approaches are recommended for effective CIBP management.

Conclusions:

• Effective CIBP management necessitates understanding its complex pathophysiology.
• A combination of therapeutic modalities is crucial for optimizing patient outcomes and QoL.
• Ongoing research is vital for developing novel and improved CIBP treatments.